Understanding COVID - 19 pandemic – A comprehensive Ayurvedic perspective

2011, vol. I 2018, vol. I 2016 2018, vol. 2 2011, vol. I Sen, 2005, Bhaishajya Ratnavali (Sanskrit).1st ed. Varansi:Chaukhamba Surbharati prakashan; 2005 Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City area, JAMA, 323, 2052, 10.1001/jama.2020.6775 Wu, 2020, Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries, Sci Total Environ, 729, 139051, 10.1016/j.scitotenv.2020.139051 2007 Ji Maharaj, 2006 2017, vol. 2 2011 1981 1930, vol. 2, 157 Raju, 2008, BasavRajeeyamu (Sanskrit).1st ed. Rajamundri: ABS Publishers; 2008, 207 2008, 475 1981 1981 Jyothi, 2016, Vatsanabha: an agada perspective, IAMJ, 4 Singh, 2016, An appraisal of the bioavailability enhancers in Ayurveda in the light of recent Pharmocological Advances, AYU, 37, 3, 10.4103/ayu.AYU_11_15 Sharma, 2015, Antidiabetic claims of Tinospora Cordifolia (Willd.) Miers: critical appraisal and role in therapy, Asian Pacific J Trop Biomed, 5, 68, 10.1016/S2221-1691(15)30173-8 Mahadevan L. M.D, Ph.D. Director &Chief Consultant of Sri Sarada Ayurveda Vaidya Sala, Derisanamcope, Kanyakumari. Personal Communications.